secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2024-03-21T23:59:59+00:00
Accession:  0001493152-24-010741
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics resolves Nasdaq delisting notice, regains compliance with bid price rule
--------------------------------------------------------------------------------

- Regained compliance with Nasdaq Listing Rule 5550(a)(2) on March 19, 2024.
- Closing bid price stayed above $1.00 for ten consecutive trading days (Mar 5-18, 2024).
- Previously faced potential delisting by May 19, 2024; notice now closed.
- Original deficiency notice received Nov 21, 2023 for bid price below $1.00 for 30 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224010741/0001493152-24-010741-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224010741/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-010741

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer